Coherus Oncology (CHRS) Change in Accrued Expenses (2013 - 2026)
Coherus Oncology's Change in Accured Expenses came in at -$1.28 million for Q2 2026, compared with -$6.59 million a year earlier.
Powered by 
Analysis
Coherus Oncology (CHRS) Change in Accrued Expenses (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Coherus Oncology reported Change in Accured Expenses of -$2.73 million; for FY2025, it was -$9.2 million.
- Going back by year, Change in Accured Expenses was -$56.88 million in FY2024, $10.92 million in FY2023 (+813.6%), $1.2 million in FY2022 (-93.3%) and $17.93 million in FY2021 (+188.7%).
- The five-year range for quarterly Change in Accured Expenses is -$47.43 million (Q2 2024) to $40.9 million (Q3 2022).
- Business Quant data shows CHRS's Change in Accured Expenses at -$7.16 million (Q1 2026), $4.44 million (Q4 2025) and $1.28 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | - |
| 10 | Coherus Oncology | 119.30 Mn | -516.84 Mn | 10.07 Mn | -1.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.28 Mn |
| Mar 31, 2026 | -7.16 Mn |
| Dec 31, 2025 | 4.44 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | -6.59 Mn |
| Mar 31, 2025 | -8.33 Mn |
| Dec 31, 2024 | -5.97 Mn |
| Sep 30, 2024 | -5.03 Mn |
| Jun 30, 2024 | -47.43 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 19.73 Mn |
| Sep 30, 2023 | 484,000.00 |
| Jun 30, 2023 | 12.62 Mn |
| Mar 31, 2023 | -21.91 Mn |
| Dec 31, 2022 | -31.12 Mn |
| Sep 30, 2022 | 40.90 Mn |
| Jun 30, 2022 | -1.44 Mn |
| Mar 31, 2022 | -7.14 Mn |
| Dec 31, 2021 | 1.41 Mn |
| Sep 30, 2021 | -9.94 Mn |
API Access
Coherus Oncology Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();